REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

UK BROKER RATINGS SUMMARY: Bank Of America Downgrades Morrisons

Mon, 06th Jan 2020 09:37

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

----------

FTSE 100

----------

BANK OF AMERICA CUTS WM MORRISON SUPERMARKETS TO 'UNDERPERFORM' ('NEUTRAL')

----------

GOLDMAN SACHS RAISES BP PRICE TARGET TO 750 (730) PENCE - 'CONVICTION BUY LIST'

----------

MORGAN STANLEY RAISES GLAXOSMITHKLINE PRICE TARGET TO 1740 (1640) PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY RAISES ASTRAZENECA PRICE TARGET TO 8100 (7400) PENCE - 'EQUAL-WEIGHT'

----------

SOCGEN CUTS NEXT TO 'SELL' ('HOLD') - TARGET 6588 (6301) PENCE

----------

BERNSTEIN RAISES DIAGEO PRICE TARGET TO 3400 (3250) PENCE - 'MARKET-PERFORM'

----------

BARCLAYS RAISES ASHTEAD GROUP PRICE TARGET TO 3195 (2430) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES GLAXOSMITHKLINE PRICE TARGET TO 1900 (1700) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES ASTRAZENECA PRICE TARGET TO 8500 (7900) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS HIKMA PHARMACEUTICALS TO 'UNDERWEIGHT' ('NEUTRAL') - TARGET 1850 (1800) PENCE

----------

DEUTSCHE BANK RAISES AVIVA PRICE TARGET TO 470 (450) PENCE - 'HOLD'

----------

DEUTSCHE BANK RAISES HARGREAVES LANSDOWN PRICE TARGET TO 1800 (1700) PENCE - 'HOLD'

----------

DEUTSCHE BANK RAISES LEGAL & GENERAL PRICE TARGET TO 335 (290) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES STANDARD LIFE PRICE TARGET TO 320 (265) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS ST JAMES'S PLACE TO 'HOLD' ('BUY') - TARGET 1220 (1190) PENCE

----------

DEUTSCHE BANK RAISES PRUDENTIAL PRICE TARGET TO 1500 (1450) PENCE - 'HOLD'

----------

FTSE 250

----------

UBS RAISES SHAFTESBURY PRICE TARGET TO 915 (860) PENCE - 'NEUTRAL'

----------

UBS RAISES GREAT PORTLAND PRICE TARGET TO 965 (830) PENCE - 'BUY'

----------

UBS RAISES DERWENT LONDON PRICE TARGET TO 4425 (3750) PENCE - 'BUY'

----------

JPMORGAN CUTS ASTON MARTIN LAGONDA PRICE TARGET TO 500 (570) PENCE - 'NEUTRAL'

----------

JEFFERIES RAISES SERCO GROUP PRICE TARGET TO 185 (170) PENCE - 'BUY'

----------

JEFFERIES RAISES MARKS & SPENCER PRICE TARGET TO 230 (207) PENCE - 'HOLD'

----------

JEFFERIES RAISES HAYS PRICE TARGET TO 165 (145) PENCE - 'HOLD'

----------

JEFFERIES CUTS PAGEGROUP TO 'HOLD' ('BUY') - TARGET 555 (540) PENCE

----------

OTHER MAIN MARKET AND AIM

----------

BARCLAYS RAISES JOHNSON SERVICE GROUP TARGET TO 220 (210) PENCE - 'OVERWEIGHT'

----------

DEUTSCHE BANK RAISES JUST GROUP PRICE TARGET TO 70 (54) PENCE - 'HOLD'

----------

JEFFERIES CUTS GAMMA COMMUNICATIONS TO 'HOLD' (BUY) - TARGET 1280 (1320) PENCE

----------

BERENBERG RAISES ON THE BEACH GROUP PRICE TARGET TO 540 (480) PENCE - 'BUY'

----------

BERENBERG RAISES HOLLYWOOD BOWL PRICE TARGET TO 310 (280) PENCE - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

Related Shares

More News
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was ...

7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announ...

3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.